1. Home
  2. WBX vs PRQR Comparison

WBX vs PRQR Comparison

Compare WBX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$2.62

Market Cap

63.8M

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.63

Market Cap

262.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WBX
PRQR
Founded
2015
2012
Country
Spain
Netherlands
Employees
696
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.8M
262.5M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
WBX
PRQR
Price
$2.62
$1.63
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
$4.00
★ $7.78
AVG Volume (30 Days)
14.4K
★ 646.8K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.25
Revenue Next Year
$142.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$1.33
52 Week High
$7.83
$3.10

Technical Indicators

Market Signals
Indicator
WBX
PRQR
Relative Strength Index (RSI) 34.16 31.81
Support Level $2.35 $1.64
Resistance Level $3.12 $1.99
Average True Range (ATR) 0.15 0.08
MACD -0.04 -0.02
Stochastic Oscillator 9.10 10.00

Price Performance

Historical Comparison
WBX
PRQR

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: